Article Library
Scarinci Hollenbeck regularly publishes articles pertaining to legal updates affecting individuals and institutions in New York and New Jersey, and the world at large. Here you can find coverage for when we welcome new attorneys, significant wins we’ve secured on behalf of our clients, and general announcements.
Results for hemp articles
Key Takeaways from the FDA’s Review of CBD Products for Mislabeling and Adulteration
Author: Daniel T. McKillopDate: July 27, 2020
The U.S. Food and Drug Administration (FDA) recently sent an overdue report to Congress regarding its review of cannabidiol (CBD) products for mislabeling and adulteration. The FDA report revealed that mislabeling and adulteration are not widespread, it did find that the actual CBD content in many products did not match the content described in these products’ labeling.
According to the FDA, its findings support the need for additional studies. “FDA believes that understanding the characteristics of marketed CBD products is critical to making informed decisions about how best to protect public health in the current marketplace,” the report states.
Financial Regulators Seeking to Help Hemp Businesses Access Banking Services
Several financial regulators recently issued a statement making it easier for banks to provide services to hemp businesses... The Board...
Plant Patent 101 for Cannabis and Hemp Businesses
A Plant Patent is an Intellectual Property Right That Protects a Distinct and New Variety of Plant - CWB Holdings...
Hemp Growers Can Now Obtain Federal Crop Insurance
The U.S. Department of Agriculture Recently Announced that Industrial Hemp Growers Can Qualify for Crop Insurance The U.S. Department of...
Federal Credit Unions Cleared to Provide Financial Services to Legal Hemp Industry
The National Credit Union Administration (NCUA) Recently Issued Guidance Giving Federally Insured Credit Unions the Green Light to Service the...
